MAP3K2

Mitogen-Activated Protein Kinase Kinase Kinase 2

Gene Information Card

Symbol MAP3K2
Full Name Mitogen-Activated Protein Kinase Kinase Kinase 2
Gene Type protein-coding
Chromosomal Location 2q31.1
NCBI Gene ID 10746 ncbi.nlm.nih.gov/gene/10746
Ensembl ID ENSG00000134138
UniProt ID Q9Y2U5
OMIM ID 601334
HGNC ID 6855
Aliases MEKK2, MAPKKK2

Description

MAP3K2 (Mitogen-Activated Protein Kinase Kinase Kinase 2) encodes a serine/threonine kinase that functions as a MAP3K in the MAPK signaling cascade. It specifically activates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7. The protein contains a PB1 domain that mediates interactions with other signaling proteins and is involved in cellular responses to growth factors, cytokines, and stress stimuli.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various types) MAP3K2 mutations and overexpression can dysregulate MAPK signaling, promoting cell proliferation and survival COSMIC; ClinVar
Cardiovascular diseases Altered MAP3K2 activity may contribute to cardiac hypertrophy and vascular remodeling NCBI Gene; PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 12.5 Medium
Brain 8.3 Low
Lung 15.2 Medium
Liver 6.1 Low
Kidney 18.7 Medium
Testis 22.4 High
Cell Line Expression
Cell Line nTPM Notes
HEK 293 20.1 Embryonic kidney cells
HeLa 15.8 Cervical cancer cells
A549 12.3 Lung cancer cells
MCF7 9.7 Breast cancer cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
p.Glu207Lys Missense <1% Unknown functional impact
p.Arg441* Nonsense <1% Likely loss of function
p.Val580Met Missense <1% Reported in COSMIC
Mutation functional classification

Loss of Function (LOF)

Nonsense mutations (e.g., p.Arg441*) are predicted to truncate the kinase domain, reducing or abolishing catalytic activity.

Gain of Function (GOF)

Some missense mutations in the kinase domain may enhance activity, but specific gain-of-function variants are not well characterized.

Dominant Negative (DN)

No dominant-negative mutations have been formally described for MAP3K2.

Pathways

• MAPK signaling pathway (KEGG: hsa04010)
• JNK cascade (Reactome: R-HSA-450294)
• ERK5 cascade (Reactome: R-HSA-198753)

Protein Summary

MAP3K2 (MEKK2) is a 619-amino-acid serine/threonine kinase with an N-terminal PB1 domain and a C-terminal kinase domain. It acts as a MAP3K that phosphorylates and activates MKK5 and MKK7, leading to ERK5 and JNK activation, respectively. The protein is widely expressed and plays roles in cell proliferation, differentiation, and stress responses.

Related Products

Product name Cat.No. Species Gene ID
MAP3K2 Knockout HEK293 Cell Line EDJ-KQ689 Human 10746 Details Get a Quote
MAP3K20 Knockout HEK293 Cell Line EDJ-KQ690 Human 51776 Details Get a Quote
MAP3K21 Knockout HEK293 Cell Line EDJ-KQ10092 Human 84451 Details Get a Quote
MAP3K2 Knockout A-549 Cell Line EDJ-KQ18131 Human 10746 Details Get a Quote
MAP3K21 Knockout A-549 Cell Line EDJ-KQ35936 Human 84451 Details Get a Quote
MAP3K21 Knockout HCT 116 Cell Line EDJ-KQ37168 Human 84451 Details Get a Quote
MAP3K21 Knockout HeLa Cell Line EDJ-KQ37169 Human 84451 Details Get a Quote
MAP3K2 Knockout HCT 116 Cell Line EDJ-KQ19248 Human 10746 Details Get a Quote
MAP3K2 Knockout HeLa Cell Line EDJ-KQ19249 Human 10746 Details Get a Quote
MAP3K20 Knockout A-549 Cell Line EDJ-KQ19250 Human 51776 Details Get a Quote
MAP3K20 Knockout HCT 116 Cell Line EDJ-KQ19251 Human 51776 Details Get a Quote
MAP3K20 Knockout HeLa Cell Line EDJ-KQ19252 Human 51776 Details Get a Quote
Displaying Records 1 To 12 Of 12 Records
Contact Us
*
*
*
*
How did you hear about us: